✦ LIBER ✦

The Role of Plasmapheresis Therapy for Perioperative Management in ABO-Incompatible Adult Living Donor Liver Transplantation

✍ Scribed by T. Ashizawa; N. Matsuno; T. Yokoyama; Y. Kihara; K. Kuzuoka; S. Taira; O. Konno; Y. Jyojima; I. Akashi; Y. Nakamura; K. Hama; H. Iwamoto; T. Iwahori; T. Nagao; M. Kasahara; K. Tanaka

Book ID: 116932937
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 64 KB
Volume: 38
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2006.10.122

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic Strategy and the Role of Aph

Therapeutic Strategy and the Role of Apheresis Therapy for ABO Incompatible Living Donor Liver Transplantation

✍ Koichi Kozaki; Hiroto Egawa; Mureo Kasahara; Fumitaka Oike; Atsushi Yoshizawa; A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

The Role of Apheresis Therapy for ABO In

The Role of Apheresis Therapy for ABO Incompatible Living Donor Liver Transplantation: The Kyoto University Experience

✍ Koichi Kozaki; Hiroto Egawa; Mikiko Ueda; Fumitaka Oike; Atsushi Yoshizawa; Atsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

Feasibility of ABO-incompatible living d

Feasibility of ABO-incompatible living donor liver transplantation in the rituximab era

✍ Toru Ikegami; Ken Shirabe; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

We read with interest the articles by Chan et al. 1 (Queen Mary Hospital) and Hwang et al. 2 (Asan Medical Center), who discussed the use of donor exchange programs for living donor liver transplantation (LDLT) to avoid ABO-incompatible (ABOi) LDLT because the outcomes of ABOi LDLT are very poor. H

The role of immunomodulation in ABO-inco

The role of immunomodulation in ABO-incompatible adult liver transplant recipients

✍ Lucio Urbani; Alessandro Mazzoni; Irene Bianco; Tiziana Grazzini; Paolo De Simon 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Background: ABO‐incompatible (ABO‐i) liver transplantation (LT) is a high‐risk procedure due to the potential for antibody‐mediated rejection (AMR) and cell‐mediated rejection. The aim of the current report is to illustrate the results of a retrospective comparison study on the use

Role of Plasmapheresis as Liver Support

Role of Plasmapheresis as Liver Support for Early Graft Dysfunction Following Adult Living Donor Liver Transplantation

✍ C.-S. Park; S. Hwang; H.-W. Park; Y.-H. Park; H.-J. Lee; J.-M. Namgoong; S.-Y. Y 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 113 KB

B-cell surface marker analysis for impro

B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation

✍ Hiroto Egawa; Katsuyuki Ohmori; Hironori Haga; Hiroaki Tsuji; Kimiko Yurugi; Aya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 2 views

Although the effectiveness of rituximab has been reported in ABO blood group (ABO)-incompatible (ABO-I) organ transplantation, the protocol is not yet established. We studied the impact of the timing of rituximab prophylaxis and the humoral immune response of patients undergoing ABO-I living donor l